Hardik Parikh

Stock Analyst

(n/a)
# 4,650
Out of 4,653 analysts
4
Total ratings
n/a
Success rate
n/a
Average return

Stocks Rated by Hardik Parikh

Viking Therapeutics
Sep 11, 2024
Initiates: Overweight
Price Target: $80
Current: $55.06
Upside: +45.30%
Pacira BioSciences
Aug 12, 2024
Downgrades: Underweight
Price Target: $45$10
Current: $16.45
Upside: -39.21%
Structure Therapeutics
May 21, 2024
Initiates: Overweight
Price Target: $65
Current: $36.37
Upside: +78.72%